HomeSPRY • NASDAQ
add
ARS Pharmaceuticals Inc
Previous close
$8.39
Day range
$8.38 - $8.57
Year range
$6.66 - $18.90
Market cap
847.97M USD
Avg Volume
1.14M
P/E ratio
-
Dividend yield
-
Primary exchange
NASDAQ
In the news
Financials
Income Statement
Revenue
Net income
| (USD) | Dec 2025info | Y/Y change |
|---|---|---|
Revenue | 28.09M | -67.56% |
Operating expense | 59.96M | 68.93% |
Net income | -41.32M | -182.76% |
Net profit margin | -147.13 | -355.12% |
Earnings per share | -0.42 | -182.35% |
EBITDA | -41.05M | -186.92% |
Effective tax rate | 0.19% | — |
Balance Sheet
Total assets
Total liabilities
| (USD) | Dec 2025info | Y/Y change |
|---|---|---|
Cash and short-term investments | 244.99M | -21.98% |
Total assets | 327.65M | -6.69% |
Total liabilities | 213.39M | 126.16% |
Total equity | 114.26M | — |
Shares outstanding | 99.30M | — |
Price to book | 7.30 | — |
Return on assets | -29.60% | — |
Return on capital | -34.54% | — |
Cash Flow
Net change in cash
| (USD) | Dec 2025info | Y/Y change |
|---|---|---|
Net income | -41.32M | -182.76% |
Cash from operations | -43.48M | -203.53% |
Cash from investing | 24.11M | 123.70% |
Cash from financing | 1.13M | -98.41% |
Net change in cash | -18.24M | -263.44% |
Free cash flow | -21.79M | -190.39% |
About
Founded
2015
Website
Employees
161
